dosing Flashcards
celecoxib dose acute & prophylaxis
acute: 400mg LD -> 200mg
200mg BD (5-7d, until sx resolve)
Prophylaxis: 200mg OD
CS prednisolone dose acute & prophylaxis
- acute: 30-40mg OD (or divide to 2 dose), 2-5d until sx resolve
- Prophylaxis: 5-7.5mg OD
CS prednisolone taper
- Taper by half dose over 7d (discontinue)
- (weight) 0.5mg/kg OD 2-5 d –> taper
colchicine dose (acute flares)
max 1.5mg/day
* 1mg LD –> 0.5 mg 1hr later
* OR 0.5mg BD-TDS
colchicine prophylaxis dose
adjunct with ULT:
0.5mg OD/ BD (max 1.2mg/day)
If flare up occurs: incr dose to acute flare dose
allopurinol dose initiate and titrate
- Initiate: ≤100mg/day
- CKD stage ≥3, <50ml/min: ≤50mg/day
- Titrate: 50-100mg incr every 2-8wks
- Monitor SU, clinical resp (dose adj to target), drug toxicity SCAR
allopurinol maintain and max dose
- maintain: > 300mg/day
Max 800/day
febuxostat dose
40-80mg OD
Initiate: ≤40mg/day
Titrate: 80mg/day
If target not met after 2-4 wks
probenecid dose
- Initiate: 250mg BD 1wk –> 500mg BD
- Titrate: 500mg every 4wks
- As tolerates, to reach target
- Maintain: ≤2g/day
500-3000mg/ day
PO bisphosphonate dose
alendronate: 70mg once per week (same day)
risendronate: once a mth
(5yrs)
bispho IV dose
Zoledronic acid (IV: 5mg 30min infusion per yr)
Once a yr (15-30mins via cannula vein)
(3yrs)
romosozumab DOA
SC inj (once a mnth)
- Fatty tissue of abdomen
USED FOR 12MNTHS (1 yr)
denosumab DOA
SC inj every 6mnths
- Fatty tissue of abdomen
+ 1000mg Ca + (=/> 400 IU vit D) daily
raloxifene dose
raloxifene (60mg OD)
calcitonin
Inj (IV, SC, IM), nasal spray
teriparatide
SC inj 20mcg OD
- Fatty tissue of abdomen
MAX DURATION 24MNTHS in lifetime (2yrs)
Longer tx incr risk of osteosarcomas (mice)
vit D range
≥ 20-30ng/mL (800-1200IU)
and
≤ 50-100ng/mL (4000IU)
vit D daily intake
600IU/d (51-70yo)
800IU/d (>70yo)
vit D suppl dose
600-800IU/day cholecalciferol
vit D DDI
decr vit D: rifampicin, anticonvulsants (PT, VA, CBP)
cholestyramine, orlistat (binds to fat, vit D is fat soluble) = SPACE OUT
Al containing pdts
Ca normal range
> 2.2-2.7 mmol/L
Ca daily intake
1000 mg/day (>51yo)
800mg/day (19-51yo)
Indication: give suppl if dietary < 700 mg/day
vit Ca DDI
- Decr Ca absorption (incr pH): PPI, high fibre diet
- Decr other drug absorption: Fe, tetracycline, FQ, bisphosphonate, thyroid suppl.
= Space apart from bisphophonate!!
MTX dose
initiate 7.5mg once weeklu
titrate: 2.5-5mg/wkly (every 4-12wks based on resp)
TARGET: 15mg/day (within 4-6wks of initiate)
max: 25mg/wk
MTX dose adj
crcl < 30ml/min (<50ml = 50% dose)
pre-exist liver disease/ AST/ALT > 3X ULN (75% dose)
folic acid dose
5mg/ wk
add CS with DMARD
bridge
7.5mg mg/d up to 3mnths
* taper and discont within 3mnths
dose adj for csDMARD
MTX adj for renal (<50ml/min, AVOID in <30) and liver
sulfa adj for renal < 60ml/min
hydroxychloroquine no adj, caution
leflunomide adj for liver (AVOID ALT >2xULN)
ROA for bDMARD
- anti-TNF (infliximab (IV), adalimumab (SC), etanercept (SC))
- IL1R antagonist: Anakinra (SC)
- Anti CTLA4 IG: Abatacept (IV, sc)
- Anti-CD20: rituximab (IV)
- Anti-IL6 receptor mAb: tocilizumab (IV)
- JAKi tofacitinib (PO)
naproxen dose
More effective in women (Fu >40%, lower dose more potent)
T1/2: 12-14hrs
Indication: dysmenorrhea, MSK
- LD: 220-500mg
- Maintain: 220-250mg tab Q8H – Q12h
- max 750mg/d
indomethacin
Strongly anti-inflamm due to additional steroid-like Phospholipase A inhibition
- indication: gout
- ADR: 15-25% report confusion, depression, psychosis, hallucination also occur
diclofenac
Short plasma t1/2: < 2hr
Indication: MSK (RA, OA). Accumulates in synovial fluid, longer t1/2
- ADR: low GI risk
celecoxib dose
acute pain
400mg initial, 200mg later 12h
200mg BD prn
paracetamol dose
500mg-1g QDS (narrow TI for liver toxicity)
paracetamol monitor what dose
- Can lead to liver damage
- Refer =/> 10g / 24hr to ED
- Incr risk of harm with doses =/> 4g/ 24hr
tramadol dose
mod-severe pain
acute pain
* initiate 50mg q4-6h~ 100mg
* max 400mg/d
chronic pain
* initiate 25-50mg q6h ~ 100mg
* max 400mg/d
- TNFa
- IL6i
- IL1RA
- anti CD20
- anti CTLA4
- TNFa
- infliximab
- etanercept
- adalimumab
- IL6i
- tocilizumab
- IL1RA
- anakinra
- anti CD20
- rituximab
- anti CTLA4
- abatacept
methotrexate caution, ci
caution: CRCL < 30 (avoid)
>3x ULN
CI: PREEXISTING LIVER DISEASE
immunodef syndrome
blood dyscrasia
teroteogenic
methotrexate DDI
NSAID, COX2i
PPI
probenecid
vaccines
alcohol
sulfasalazine cautions and CI
caution (<60ml/min)
CI: sulfonamide allergies, G6PD def
sulfasalazine ddi
Fe, Abx, warfarin
hydroxychloroquine cautions and CI
CI: pre-existing retinopathy
hydroxychloroquine DDI
CYP2C9i: cimetidine
QT prolong: ciprofloxacin
leflunomide cautions and CI
caution: x2 ULN
CI: pre-exist liver disease
immunodef state
leflunomide DDI
cholestyramine
charcoal, warfarin, vaccine, alcohol